For the past month, Johnson & Johnson's (NYSE:JNJ) share price has followed the long-term trend in health care spending, moving steadily up and to the right. With shares now sitting near their 52-week and all-time highs, our health-care bureau chief Brenton Flynn was anxiously awaiting today's earnings report to take a pulse on the $200 billion health care giant.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.